Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma × palbociclib × Clear all

Phase

Status

Completed 3 Active not recruiting 3 Withdrawn 1 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 17 Neoplasms 5 Neoplasm Metastasis 4 Ovarian Neoplasms 3 Endometrial Neoplasms 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Colorectal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Breast Diseases 2 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors Refractory to Standard Therapy 1 Solid Tumor, Adult 1 Solid Tumor 1 Sarcoma 1 Rare Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neoplasms by Site 1 Neoplasm, Residual 1 Melanoma 1 Malignant Female Reproductive System Neoplasm 1 Lung Neoplasms 1 Liposarcoma, Myxoid 1

Interventions

Doxorubicin 14 pembrolizumab 9 Gemcitabine 8 Surgical Procedures, Operative 7 Nivolumab 6 Blood Specimen Collection 6 Trabectedin 5 Surveys and Questionnaires 5 Ifosfamide 5 Drug Therapy 5 Cyclophosphamide 5 Radiotherapy 4 Radiation Dose Hypofractionation 4 liposomal doxorubicin 3 fludarabine 3 atezolizumab 3 anlotinib 3 Radiation 3 Observation 3 Ipilimumab 3 Docetaxel 3 Biopsy 3 trastuzumab deruxtecan 2 selinexor 2 repotrectinib 2 pazopanib 2 fluzoparib 2 fludarabine phosphate 2 eribulin 2 cabozantinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06113809 2025-06-03

Palbociclib and Pembrolizumab in Sarcoma

University of Iowa

Phase 1 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡